525 results on '"Ferraro, Diana"'
Search Results
2. Progression independent of relapse activity in relapsing multiple sclerosis: impact and relationship with secondary progression
3. Correction to: Progression independent of relapse activity in relapsing multiple sclerosis: impact and relationship with secondary progression
4. ChatGPT vs. neurologists: a cross-sectional study investigating preference, satisfaction ratings and perceived empathy in responses among people living with multiple sclerosis
5. Immunosenescence and vaccine efficacy revealed by immunometabolic analysis of SARS-CoV-2-specific cells in multiple sclerosis patients
6. Late-onset multiple sclerosis: disability trajectories in relapsing–remitting patients of the Italian MS Registry
7. Evaluation of drivers of treatment switch in relapsing multiple sclerosis: a study from the Italian MS Registry
8. SARS-CoV-2 vaccination and multiple sclerosis: a large multicentric study on relapse risk after the third booster dose
9. Kappa index in the diagnostic work-up of autoimmune encephalitis
10. Disease-modifying therapies in managing disability worsening in paediatric-onset multiple sclerosis: a longitudinal analysis of global and national registries
11. Patients with multiple sclerosis choose a collaborative role in making treatment decision: results from the Italian multicenter SWITCH study
12. Is It Time for Ocrelizumab Extended Interval Dosing in Relapsing Remitting MS? Evidence from An Italian Multicenter Experience During the COVID-19 Pandemic
13. Clinical relevance of thymic and bone marrow outputs in multiple sclerosis patients treated with alemtuzumab
14. Management of hepatitis B virus prophylaxis in patients treated with disease-modifying therapies for multiple sclerosis: a multicentric Italian retrospective study
15. Comparative Effectiveness and Cost-Effectiveness of Natalizumab and Fingolimod in Patients with Inadequate Response to Disease-Modifying Therapies in Relapsing-Remitting Multiple Sclerosis in the United Kingdom
16. SARS-CoV-2 Vaccination Responses in Anti-CD20-Treated Progressive Multiple Sclerosis Patients Show Immunosenescence in Antigen-Specific B and T Cells.
17. Long-term outcomes in patients presenting with optic neuritis: Analyses of the MSBase registry
18. A voxel-based lesion symptom mapping analysis of chronic pain in multiple sclerosis
19. Exit Strategies in Natalizumab-Treated RRMS at High Risk of Progressive Multifocal Leukoencephalopathy: a Multicentre Comparison Study
20. Therapeutic choices and disease activity after 2 years of treatment with cladribine: An Italian multicenter study (CladStop).
21. Timing of high-efficacy therapy for multiple sclerosis: a retrospective observational cohort study
22. Characteristics and treatment of Multiple Sclerosis-related trigeminal neuralgia: An Italian multi-centre study
23. Correction to: Management of hepatitis B virus prophylaxis in patients treated with disease-modifying therapies for multiple sclerosis: a multicentric Italian retrospective study
24. Cell-based assays for the detection of MOG antibodies: a comparative study
25. Risk of Getting COVID-19 in People With Multiple Sclerosis: A Case-Control Study
26. The real-world effectiveness of natalizumab and fingolimod in relapsing-remitting multiple sclerosis. An Italian multicentre study
27. Incidence of pregnancy and disease-modifying therapy exposure trends in women with multiple sclerosis: A contemporary cohort study
28. Disease-modifying therapies in managing disability worsening in paediatric-onset multiple sclerosis: a longitudinal analysis of global and national registries
29. Ocrelizumab Extended Interval Dosing in Primary Progressive Multiple Sclerosis: An Italian Experience
30. Effect of Disease Modifying Therapy on Disability in Relapsing-Remitting Multiple Sclerosis Over 15 Years
31. Predictors of relapse and disability progression in MS patients who discontinue disease-modifying therapy
32. Treatment Response Score to Glatiramer Acetate or Interferon Beta-1a
33. Lymphocyte reconstitution after DMF discontinuation in clinical trial and real-world patients with MS
34. Platelet Function Testing in Patients with Acute Ischemic Stroke: An Observational Study
35. Multiple Sclerosis Progression and Relapse Activity in Children.
36. Effectiveness of multiple disease- modifying therapies in relapsing- remitting multiple sclerosis: causal inference to emulate a multiarm randomised trial.
37. Systematic assessment and characterization of chronic pain in multiple sclerosis patients
38. Intrathecal oligoclonal bands synthesis in multiple sclerosis: is it always a prognostic factor?
39. Disability accrual in primary and secondary progressive multiple sclerosis
40. Previously independent patients with mild-symptomatic COVID-19 are at high risk of developing cognitive impairment but not depression or anxiety
41. Comparative effectiveness in multiple sclerosis: A methodological comparison
42. Variability of the response to immunotherapy among subgroups of patients with multiple sclerosis
43. Prognostic relevance of quantitative and longitudinal MOG antibody testing in patients with MOGAD: a multicentre retrospective study
44. Variability of the response to immunotherapy among subgroups of patients with multiple sclerosis
45. “Better explanations” in multiple sclerosis diagnostic workup: A 3-year longitudinal study
46. Cerebrospinal fluid CXCL13 in clinically isolated syndrome patients: Association with oligoclonal IgM bands and prediction of Multiple Sclerosis diagnosis
47. Prognostic relevance of quantitative and longitudinal MOG antibody testing in patients with MOGAD: a multicentre retrospective study
48. Disability accrual in primary and secondary progressive multiple sclerosis
49. Definitive childlessness in women with multiple sclerosis: a multicenter study
50. A multicenter study on the diagnostic significance of a single cerebrospinal fluid IgG band
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.